Corvus Pharmaceuticals
CRVS
CRVS
85 hedge funds and large institutions have $202M invested in Corvus Pharmaceuticals in 2024 Q4 according to their latest regulatory filings, with 32 funds opening new positions, 30 increasing their positions, 12 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
more call options, than puts
Call options by funds: $ | Put options by funds: $
37% more funds holding
Funds holding: 62 → 85 (+23)
27% more capital invested
Capital invested by funds: $159M → $202M (+$43.3M)
10.72% more ownership
Funds ownership: 48% → 58.72% (+11%)
Holders
85
Holding in Top 10
2
Calls
$15.5M
Puts
$10.1M
Top Buyers
| 1 | +$14.3M | |
| 2 | +$11.4M | |
| 3 | +$5.35M | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$4.26M |
| 5 |
VC
Vivo Capital
Palo Alto,
California
|
+$3.94M |
Top Sellers
| 1 | -$13.6M | |
| 2 | -$1.71M | |
| 3 | -$1.08M | |
| 4 |
Millennium Management
New York
|
-$837K |
| 5 |
Connor, Clark & Lunn Investment Management (CC&L)
Vancouver,
British Columbia, Canada
|
-$724K |